Literature DB >> 21987117

Kinetic investigation of myeloperoxidase upon interaction with copper, cadmium, and lead ions.

Maryam Shabani1, Mohsen Ani1, Ahmad Movahedian1, Seyed Ziyae Aldin Samsam Shariat1.   

Abstract

BACKGROUND: Myeloperoxidase (MPO), which is abundantly expressed in neutrophils, catalyzes the formation of a number of reactive oxidant species. However, evidence has emerged that MPO-derived oxidants contribute to tissue damage and initiation and propagation of inflammatory diseases, particularly, cardiovascular diseases. Therefore, studying the regulatory mechanisms of the enzyme activity is of great importance. For clarifying some possible mechanism of the enzyme activity, kinetic investigations of MPO in the presence of Copper (Cu), Cadmium (Cd), and Lead (Pb) ions were carried out in vitro.
METHODS: MPO was partially purified from human white blood cells using ion-exchange and gel-filtration chromatography techniques. Its activity was measured spectrophotometrically by using tetramethyl benzidine (TMB) as substrate.
RESULTS: Purified enzyme had a specific activity of 21.7 U/mg protein with a purity index of about 0.71. Cu inhibited MPO activity progressively up to a concentration of 60 mM at which about 80% of inhibition achieved. The inhibition was non-competitive with respect to TMB. An inhibitory constant (Ki) of about 19 mM was calculated from the slope of repot. Cd and Pb did not show any significant inhibitory effect on the enzyme activity.
CONCLUSION: The results of the present study may indicate that there are some places on the enzyme and enzyme-substrate complex for Cu ions. Binding of Cu ions to these places result in conformational changes of the enzyme and thus, enzyme inhibition. This inhibitory effect of Cu on the enzyme activity might be considered as a regulatory mechanism on MPO activity.

Entities:  

Keywords:  Myeloperoxidase; Copper; Enzyme inhibition; Cadmium; Lead

Mesh:

Substances:

Year:  2011        PMID: 21987117      PMCID: PMC3639747     

Source DB:  PubMed          Journal:  Iran Biomed J        ISSN: 1028-852X


  31 in total

1.  Further evidence for the role of myeloperoxidase in the activation of benzo[a]pyrene-7,8-dihydrodiol by polymorphonuclear leukocytes.

Authors:  A Trush; R L Esterline; W G Mallet; D R Mosebrook; L E Twerdok
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  Growing significance of myeloperoxidase in non-infectious diseases.

Authors:  Aline Hoy; Brigitte Leininger-Muller; Dolphe Kutter; Gérard Siest; Sophie Visvikis
Journal:  Clin Chem Lab Med       Date:  2002-01       Impact factor: 3.694

Review 4.  The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids.

Authors:  C M Spickett; A Jerlich; O M Panasenko; J Arnhold; A R Pitt; T Stelmaszyńska; R J Schaur
Journal:  Acta Biochim Pol       Date:  2000       Impact factor: 2.149

5.  Plasma lipoperoxidative markers in ischaemic stroke suggest brain embolism.

Authors:  G Re; G Azzimondi; C Lanzarini; L Bassein; I Vaona; C Guarnieri
Journal:  Eur J Emerg Med       Date:  1997-03       Impact factor: 2.799

Review 6.  Myeloperoxidase: friend and foe.

Authors:  Seymour J Klebanoff
Journal:  J Leukoc Biol       Date:  2005-02-02       Impact factor: 4.962

7.  Crystallization and properties of myeloperoxidase from normal human leukocytes.

Authors:  Y Morita; H Iwamoto; S Aibara; T Kobayashi; E Hasegawa
Journal:  J Biochem       Date:  1986-03       Impact factor: 3.387

8.  Neuronal expression of myeloperoxidase is increased in Alzheimer's disease.

Authors:  Pattie S Green; Armando J Mendez; Jason S Jacob; Jan R Crowley; Whit Growdon; Bradley T Hyman; Jay W Heinecke
Journal:  J Neurochem       Date:  2004-08       Impact factor: 5.372

9.  The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.

Authors:  Constanze Bergt; Subramaniam Pennathur; Xiaoyun Fu; Jaeman Byun; Kevin O'Brien; Thomas O McDonald; Pragya Singh; G M Anantharamaiah; Alan Chait; John Brunzell; Randolph L Geary; John F Oram; Jay W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

10.  Assay method for myeloperoxidase in human polymorphonuclear leukocytes.

Authors:  K Suzuki; H Ota; S Sasagawa; T Sakatani; T Fujikura
Journal:  Anal Biochem       Date:  1983-07-15       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.